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Abstract 
Background: At about 1% of live births worldwide, Congenital Heart Defects (CDH) is the 
most common major congenital defects worldwide. Since the 1950s, survival of these patients 
into adulthood has increased from 20% to 95%. As a consequence, patients with a CHD are 
steadily increasing in numbers, age and severity of the CHD but we have limited knowledge 
regarding the long term consequences and succeptability for risk factors and old age. It has 
been suggested, for instance, that they are prone to myocardial infarction (MI), but we do not 
know to what extent our diagnostic criteria applies to these patients. The aim of this study is 
to validate the diagnostics of MI in adult patients with CHD. 
Method: A search was conducted in Elvis, the administative database of Västra 
Götalandsregionen of Sweden, and all patients with a CHD and an MI diagnosis were 
included. The medical records were retrieved and used to evaluate the basis for the MI 
diagnosis. The evaluation was performed using a modified version of a standard questionnaire 
for validation of potential cases of acute myocardial infarction. The diagnosis was then 
categorized as either correct, probable, improbable or incorrect.  
Results: 32 patients were eligable for this study and accessible for evaluation. 65.6% (n = 21) 
of MI-diagnoses were classified as correct and 81.3% (n = 26) as either correct or probable, 
wich is lower than MI in the general population. Cases classified as incorrect or improbable 
were typically the result of difficulties in evaluating signs of old myocardial infarction or 
myocardial damage during surgical procedures. 
Conclusion: Adult patients with a CHD seems to recieve an incorrect MI-diagnosis more 
often than in the general population, but not in the setting of the emergency ward. More 
studies with larger cohorts are needed. 
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Abbreviations: 
• CHD: Congenital heart disease 
• ACHD: Adult with congenital heart disease 
• MI: Myocardial infarction 
• CAD: Coronary artery disease 
• PPV: Positive predictive value 
• IPR: Swedish Inpatient register 
• PFO: Persistent foramen ovale 
 
Introduction: 
The heart 
The heart is, quite simply, a pump. Or to be more precise – it is a parallel two-circuit pump 
where the right system receives deoxygenated blood from the body and pumps it into the 
lungs where it is filled with oxygen. The left system then recieves the oxygenated blood from 
the lungs and pumps it out to the body where it is used in the creation of energy and thus – 
critical for every living cell in the body. As one might expect, the embryonic development of 
the heart, being so critical for life and function, is a tightly controlled process. Even so – some 
kind of malfunction in this process occurs in about 1 in 100 babys born worldwide, and it is 
actually the most common major congenital defect. In order to understand these processes you 
need some kind of basic understanding of the embryonic development of the heart. 
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Development of the heart 
The formation of the heart starts as two parallel tubes aligned along the axis of the body 
where the blood flows in a single linear stream from the caudal to the cranial end. These tubes 
then fuse, enlongates, loops, folds and grows in just the right way to create a primitive heart 
consisting of an upper chamber, the primitive atria, and lower chamber, the primitive 
ventricle, as well as an inflow and an outflow region.  
But there is still only a linear, single-circuit flow of blood throughout, not the two-circuit 
system found in a mature heart. This is accomplished by the simultaneus formation of three 
septa, the atrioventricular, atrial and ventricular septa. By creating the four valves, one for 
each chamber, and separating the outflow of blood into one pulmonary and one systemic 
circuit, the heart finally reaches its mature configuration. 
Given this complex process, and the essential function of the heart, it is no surprise that it is a 
tightly controlled process. Even so, each step of the way can go awry, and when it does the 
Figure 1 – Featal development of the heart related to number of days from conception 
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result is a congenital heart defect. If the malformation is severe enough the result is a 
spontaeus termination of the pregnancy. The malformation may also be so insignificant that 
the faetus is not only brought to term, but may also live a long and healthy life without 
becoming aware of it. There is also, of course, everything in between. 
Congenital heart defects 
As stated above, congenital heart defects (CHD) is present in about 1% of live births 
worldwide  [1, 2, 3], which makes it the most common of all major congenital anomalies [4]. 
These conditions range substantually in severity - from those who sometimes can be 
asymtomatic and self-healing, such as atrial septal defects (ASD) and ventricular septal 
defects (VSD), to more severe conditions such as hypoplastic left heart syndrome, which is 
not compatible with life beyond 6-12 months of life without several surgical corrective 
procedures. Other conditions may also require surgery but may still be associated with 
hypoxia, arrhythmias or heart failure, even after corrective surgury. 
During the second half of the last century, the treatment of patients with congenital heart 
disease has improved dramatically, and today almost 95% of infants born with CHD survive 
into adulthood [5]. The increase is primarily seen among patients with more severe defects, 
but the trend is visible in mild and severe defects as well [6]. Even though this is a remarkable 
development, these patients nevertheless face multiple cardiovascular complications and the 
healthcare utilization rates of these patients are significantly higher compared to non-CDH 
adults [7]. They are, for instance, at a higher risk of arrhythmias [8] [9], ischemic stroke [9] 
[10], endocarditis [11] and congestive heart failure as well as hypertension [11] compared to 
the general population. And because of the heterogeneity within the group, the risk factors of 
individuals vary greatly, depending on the nature and severity of the underlying condition. 
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Overall, the more severe the underlying condition is, the higher the susceptability to the risk 
factors mentioned above [12]. 
This development has also lead to dramatic changes in the population with adult congenital 
heart defect (ACHD), primarily in three aspects:  
1. As more and more individuals are surviving into adulthood, the population with an 
ACHD are steadily increasing in numbers [13].  
2. The median age of this patient group is increasing, making them more susceptible to 
risk factors related to old age. Indeed, the main determinants of mortality among this 
group is no longer attributed to the heart defect, but to acquired general medical 
conditions [14]. This is examplifyed further by the fact that the mortality rates in 
congenital heart diseases has shifted from the very young to the old [15] 
3. The increased survival rates primarily reflect an improved treatment of patients with 
more severe and complex heart defects. In other word, many adults now live with a 
defect which just a couple of decades ago would lead to an early death. As a result 
these patients, as a group, now have more severe heart defects then before [6], some 
completely “new” as a diagnosis in adults. 
Aspects of Coronary Artery Disease in ACHD 
Adults with CHD have an elevated incidence of coronary artery disease (CAD) at a young age 
(11), and MI is now the leading cause of mortality in these patients [16]. At large, the 
mechanisms behind this are still unclear, but there are some indications worth noting. 
Nature and severity of CHD-diagnosis 
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The nature and severity of the underlying anomality is surely an important factor regarding 
the risk of developing CAD. For example, patients with a CHD that entails an obstruction of 
the left ventricle or the aorta has been found to have coronary intimal hyperplasia more often 
compared to other CHD-diagnoses. In one study of paediatric patients, 100% of patients with 
these diagnoses had coronary hyperplasia (thought to represent the first stages of coronary 
atheroma), compared to 61% in of the patients with other CHD-diagnoses [17]. Also, a 
number of CHD may give rise to secondary conditions that in turn increases the risk of CAD. 
These include valvular aortic stenosis, present in about 3 - 6% of patients with ACHD, wich 
may give rise to left ventricular hypertrofy, an independent risk factor for CAD, [18], as well 
as aortic coarctation, which may give rise to systemic hypertension [17]. The possibility that 
more severe heart defects results in a higher rate of CAD is one that needs to be taken all the 
more seriously given the recent development stated above, namely that the severity of the 
underlying condition in the population with ACDH is steadily increasing. 
So in general, it is supposed that the risk of CAD and MI increases with more severe heart 
defects. But even anomalities with few structural defects that might seem harmless can 
increase the incidence of atherosclerotic lesions in the area. Examples of this are the origin of 
the left circumflex artery from the right coronary artery or an abnormal origin of the left main 
coronary artery from the right sinus of Valsalva [19]. 
Another possibility is that what historically has been percieved as an isolated CHD rather is 
the representation of a more widespread or general cardiovascular disease. This has been 
proposed regarding the narrowing of the aorta in coarctation, as well as congenital pulmonary 
stenosis [20]. In this case, it may be that the CHD is not the cause of the CAD, but they are 
rather both representations of a general cardiovascular disease. In the case of coarctation this 
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is further implied by the fact that hypertension persists in about 50% of patients with 
surgically repaired coarcation [21]. 
Surgeries 
It is worth noting that it is difficult to discern to what extent the increased prevalence of CAD 
is attributable to the nature and severity of the underlying condition or to the heart surgeries 
these patients undergo. For one thing, the patients with more severe CHD undergo a greater 
number of heart surgeries. But heart surgeries can range from closing an ASD by 
transcutaneous catheterization all the way to extremely complex procedures in multiple 
sessions, such as creating a so called Fontan circulation. So it is also true that the surgeries 
these patients need are often more advanced and complex then in less severe defect, and 
perhaps rendering an elevated risk for CAD. 
One study of pediatric patients found that the patients with surgically repaired CHD presented 
higher expression of TGF-β1, a growth factor associated with CAD, in the intimal layer than 
those who had not undergone surgical repair. They also presented coronary intimal 
hyperplasia, thought to represent the first stage of coronary atheroma, at a much higher rate 
than those without surgical repair (80% and 47,3% respectively) [17]. And in the case of 
coarctation of the aorta, approximately 5% of young adults with repaired coarctation have 
CAD, and studies have shown that CAD is the main cause of death in patients with corrected 
coarctation of the aorta [22] [23]. 
Some of these procedures, like the arterial switch, conducted to correct d-transposition of the 
great vessels, includes manipulation of the coronary arteries. This may result in turbulent 
blood flow as well as shear stress on the coronary wall, thus increasing the risk of CAD. One 
study found that this procedure may result in ostial stenosis, possibly increasing the risk of 
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atherosclerosis. It also concluded that coronary lesions occurred in 6,8% of patients who 
underwent this type of surgery [24]. Another study was conducted to assess the morphology 
of the coronary wall with a long time follow-up in children who had gone through the arterial 
switch procedure (age 5 to 22 years of age, median 9,5). Of these patients, 89% displayed 
some type of proximal eccentric intimal proliferation and 50% of these where classified as 
moderate-to-severe lesions [25].  
 
Lifestyle 
A great deal of focus regarding the development of CAD in the general population has to do 
with lifestyle. Traditionally, the risk factors associated with lifestyle include blood levels of 
total and high-density lipoprotein (HDL) cholesterol, blood pressure, cigarette use, diet and 
sedentary lifestyle [26]. It has been reported that patients with ACHD tend to live a sedentary 
lifestyle [27], a risk factor for CAD [28]. It is the case that having a CHD often leads to 
reduced exercise capacity, wich is associated with worse prognosis and increased risk of CAD 
[29] [30]. But even though the exercise capacity often is lowered, there are only a handful 
ACHD-diagnoses where exercise could be harmful and restrictions regarding exercise are 
needed. Even so, exercise is frequently not discussed or even cautioned against by as well as 
relatives as medical professionals [31]. Together, the reduced exercise capacity and obesity 
contribute to hypertension and diabetes, and several studies has found the prevalence of these 
diseases to be greater in the ACHD-population compared to age-matched controls without 
ACHD [32] [33]. Interestingly, one study from Belgium found that even though these patients 
has a lesser prevalence of smokers and more participation in sports compared to the general 
population, they more often presented hypertension and diabetes, and only 20% of these 
patients had a fully heart-healthy lifestyle. [34].  
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Closely monitored 
Patients with CHD has often from the time of birth been closely monitored regarding their 
health. They often have a personal doctor´who follows them for long periods. It could be that 
because these patients are so closely monitored in CHD clinics, CAD is found earlier and 
more frequently than the general population. 
 
What happens in the emergency ward? 
Diagnosis of CAD and MI in this patient group may be difficult; these patients often 
experience chest pains [35, 36], have abnormal electrocardiograms and elevated levels of 
Troponin T [37] as a default, effectively muddying the waters for any clinician trying to set a 
diagnosis of CAD. So what happens when a patient with a known CHD enters the ER? In a 
way there are, of course, countless scenarios depending on the situation and individuals 
involved and one might only more or less guess what might happen. But for the purpose of 
this study, the scenarios can be divided into three major scenarios. One is that the presence of 
a relatively unusual heart defect might make doctors more prone to suspect and attempt to 
falsify a MI-diagnosis. In this scenario, it would seem improbable that an experienced 
clinician would fail to detect an MI. Another scenario is that it might result in a false positive 
diagnosis, where the manifestation of the CHD is incorrectly interperated as an MI, perhaps 
leading to lifelong unneccesary medication and anxiety. Since it is unknown to what extent 
the diagnostic criteria for MI applies to patients with structural heart defect it could even be 
that the diagnosis is correct considering these criteria, even in the absence of an actual 
cardiovascular lesion. A third scenario may be that doctors may ascribe symtoms, such as 
chest pain or tachypnéa, to the CHD when it in reality may be due to an MI. Perhaps the 
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patient has had elevated TnT-enzymes, abnormal ECG, or chest pains before, and these could 
be ascribed to the CHD? How does one go about evaluating this kind of patient? The obvious 
risk of this encounter is that it may result in a false negative diagnosis, where the patient truly 
has is an myocardial infarction but does not receive the proper diagnosis and treatment. 
Myocardial Infarction diagnostics 
During the mid 1900, the diagnostic criteria for MI was not something explicit and universally 
accepted. Rather, clinicians used the criteria for MI used for reaserch by the WHO, comprised 
of the presence of two out of three criteria: 1. Typical symtoms, like chestpains. 2. Typical 
ECG-patterns. 3. typical serological markers. This created a blueprint for clinicians around the 
world when diagnosing MI, but it did leave a lot of room for interpretation. Indeed, the 
Weinstein report from 1964 [38] found that many published studies on the subject stated no, 
or highly subjective, criteria for MI. Not only did this mean that sensitivity and specificity for 
MI varied among different healthcare centers, but it also made large scale research very 
difficult. 
In Gothenburg 1975, acute myocardial infarction was considered to have occurred when at 
least two of the following three criteria (A, B and C) were fulfilled; 
• “(A) Central chest pain of more than 15 min duration and with debut within the last 
48 hr or pulmonary oedema without previously known valvular disorder or shock 
without suspicion of acute hypovolemia or intoxication. 
• (B) Transient rise of Serum Glutaminic Oxaloacetic Transaminase to values above the 
normal limits applied by the laboratory with a maximum approximately 24 hr after the 
calculated infarction debut, combined with a less pronounced increase or lack of 
increase of Serum Glutamic-Pyruvic Transaminase. 
• (C) ECG series with occurrence of pathological Q waves and/or occurrence or 
disappearance of localized ST elevations in combination with the development of T 
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inversion in at least two of the eleven routine standard leads (I, II, III, AVR, AVL, 
AVF, CR,, CR,, CR,, CR,, CR,)“ [39] 
As time went by, the accuracy of detecting myocardial infarction improved, largely as a result 
of the development of more specific biomarkers of myocardial necrosis. From glutamine-
oxaloacetic transaminase (GOT, or ASAT, as it is called nowadays) to lactate dehydrogenase 
(LDH), then creatine kinase (CK), which then could be used for assessing the MB fraction of 
CK, i.e. CKMB activity and CKMB mass [40]. A major step forward was taken with the 
discovery of Cardiac Troponin (cTn). Cardiac Troponin I and T are components of the 
contractile apparatus of myocardial cells, and are almost exclusively expressed in the heart, 
giving the test a high specificity. These are used as a marker for myocardial cell necrosis [41], 
and the detection of rise and/or fall of troponins is now a part in the diagnostic criteria 
accepted worldwide. 
Parallel to this development, the imaging techniques for examening potential MI´s has also 
improved [40, 42]. These delevopments, together with the difficulties facing clinicians and 
researches, made the need for a universal definition more and more pressing. 
There were efforts to reach this goal, and in 1971 WHO revised its criteria and included 
specific ECG-patterns, but this still required great use of clinical judgement [43]. Eventually, 
in 2000, the European Society of Cardiology and the American College of Cardiology 
Consensus group redefined myocardial infarction, with the definition being based on myocyte 
necrosis as determined by troponins in the clinical setting of ischaemia [42]. It also takes into 
account the circumstances leading to the infarction (spontaneous or during a coronary artery 
procedure) and the timing of the myocardial necrosis relative to the time of the observation 
(evolving, healing or healed MI). In 2007 came the Universal Definition of Myocardial 
Infarction, which was on the behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the 
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Redefinition of Myocardial Infarction (40). This work has later been reviewed, latest done in 
Third Universal Definition of Myocardial Infaction, published in Circulation in 2012 [41]. 
Since then, MI is defined as follows:  
“Detection of rise and/or fall of troponins with at least one value above the 99th percentile of 
the upper reference limit together with evidence of myocardial ischaemia with at least one of: 
• Symtoms of ischaemia 
• ECG changes indicative of new ischaemia (new ST-T changes or new left bundle 
branch block) 
• Development of pathological Q-waves 
• Imaging evidence of new loss of viable myocardium or new regional wall motion 
abnormality 
• Sudden, unexpected cardiac death, involving cardiac arrest, often with symptoms 
suggestive of myocardial ischaemia, and accompanied by presumably new ST 
elevation, or new left bundle branch block, and/or evidence of fresh thrombus by 
coronary angiography and/or at autopsy, but death occurring before blood samples 
could be obtained, or at a time before the appearance of cardiac biomarkers in the 
blood. 
• For percutaneous coronary interventions (PCI) in patients with normal baseline 
troponin values, elevations of cardiac biomarkers above the 99th percentile URL are 
indicative of peri-procedural myocardial necrosis. By convention, increases of 
biomarkers greater than 3 × 99th percentile URL have been designated as defining 
PCI-related myocardial infarction. A subtype related to a documented stent 
thrombosis is recognized. 
• For coronary artery bypass grafting (CABG) in patients with normal baseline 
troponin values, elevations of cardiac biomarkers above the 99th percentile URL are 
indicative of peri-procedural myocardial necrosis. By convention, increases of 
biomarkers greater than 5 × 99th percentile URL plus either new pathological Q 
waves or new LBBB, or angiographically documented new graft or native coronary 
artery occlusion, or imaging evidence of new loss of viable myocardium have been 
designated as defining CABG-related myocardial infarction” [44]. 
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The Swedish National Inpatient Register (IPR) 
The Swedish National Inpatient Register (IPR) was launched in 1964 and has had complete 
coverage on inpatient care since 1987, although it does not include outpatient care. It is 
mandatory for all physicians to deliver data to the IPR, and more than 99% of all somatic and 
psychiatric hospital discharges are now registered. Since all swedish citizens aquire an 
individual identity number and the IPR has utilized this as identification method since 1991 
(as well as retroactively). This allows research to be conducted throughout a multitude of 
registers, enabeling detailed research across disciplines on a large scale [45, 46] 
The IPR has been validated by the National Board of Health and Welfare on several occasions 
[45] [46-49] and has been validated concerning specific diagnoses numerous times. Current 
data suggest that the overall positive predictive value (PPV) of diagnoses in the register is 
about 85-95% [45]. Concerning MI, the PPV has been found to be 98-100% [47, 50] and the 
sensitivity 77-91,5% [51-54]. And though the PPV for MI is very high, there has, to the best 
of our knowledge, been no study aimed at varifying the MI-diagnosis for patients with 
ACHD. 
Considering the development seen in the patient group with ACHD, there is great need for 
further research regarding this patient group. But good research is dependent on good and 
reliable data, and there are reasons to question the data on CAD in adult patients with CHD. 
As mentioned above, the clinical charactaristics of these diseases may sometimes overlap, 
potentially resulting in an incorrect diagnosis. Indeed, it is not known to what extent the 
standard diagnostic criteria for CAD apply to adults with CHD. The effects on the life of a 
patient with ACHD given an incorrect MI-diagnosis could be severe. Despite this, there is, to 
the best of our knowledge, no study which has attempted to validate the diagnosis patients 
with a CHD-diagnosis and ischemic heart disease.  
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Summary 
The population of adults with CHD are receiving better care than previously and this entails 
new challenges. They are steadily growing in numbers, they have more severe underlying 
conditions than previously, and they are getting older and thus being exposed to the cardiac 
risk factors associated with age. They also have increased risk of CAD and MI, and reasons 
for this may be aspects regarding the nature and severity of the CHD, high rates of cardiac 
surgery and an unhealthy lifestyle. Diagnostics of MI in these patients may be difficult, since 
some of the key aspects of the diagnostic criteria for MI, such as electrocardiograms and 
biochemichal markers, may also be affected by the CHD. This may make it difficult to discern 
the CHD from an MI. And since MI is a diagnosis with high risk of adverse effects and high 
mortality, the importance of ensuring a correct diagnosis cannot be overstated. 
Aim 
The aim of this study is to validate the myocardial infarction diagnosis among patients with 
ACHD in the region of Västra Götaland. 
Method 
A datasearch was conducted in Elvis, the administative database of Västra Götalandregionen, 
to find patients with a diagnosis of any congenital heart defect (ICD Q200 to Q270) 
(diagnoses included are found in appendix 1). Among these patients we then conducted a 
search to find patients who also at some point had been diagnosed with one or more of a range 
of cardiovascular diseases, including for example acute myocardial infarction, old myocardial 
infarction, chronic artery disease and stable as well as stable angina (ICD I200 to I259). 
Because of technical reasons regarding the administrative database in question the search was 
limited to the years 2000 - 2017. These patients were then used as a ”high-risk pool” used in 
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order to search for individuals with a diagnosis of MI. Included in the study were patients 
within the Västra Götalandsregionen who was registered as having a congenital heart defect 
as well as a diagnose of myocardial infarction at some point.  
 
Figure 2 – Flow chart 
Total number of adult patients with a CHD is estimated as 4000 patients. Among these, we 
found 75 patients with a ACHD who at some point had been diagnosed with an MI or a 
cardiovascular disease of some sort. A simple search for the ICD-codes rendered 13 patients 
with a diagnosis of MI. In order to increase power and widen the search, making sure that all 
available infarction diagnoses were being analized, a free text search for ”infarction” was 
conducted in the medical journals of all patients. This procedure rendered another 28 patients 
with an MI-diagnosis, making it 41 in total. Out of the 41 patients, there were 1 patient 
without available medical records, and 8 patients registered as having a ACHD-diagnosis but 
where closer scrutiny revealed that this was incorrect. These consisted of 2 with PFO (not 
Total adult patients with a 
CHD in Västra 
Götalandsregionen
n = 4000
Patients with a CHD and 
diagnosed with a CAD 
between the years 2000-
2017 
n = 85
MI-diagnosis found by ICD-
codes
n = 13
MI-diagnosis found by 
free-text search of medical 
journals.
n = 28
CHD + MI diagnosis
N = 41 No medical journal 
available
n = 1
Incorrect CHD-diagnosis 
n = 8
Patients eligable for 
the study
N = 32
No MI-diagnosis found.
n = 44
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classified as a CHD), 2 with infarction VSD and 4 with an incorrect diagnosis all together. 
That resulted in a total of 32 patients available for evaluation. When a patient was found to 
have a diagnosis of MI, detected by the ICD-codes or by free-text searching, we searched for 
the medical journal from the hospitalization when the infarction occurred. 
We then used these records to review the basis on which the patient was diagnosed according 
to the diagnostic criteria for MI. We did not include instances where an individual patient has 
had a self-stated MI but where no such diagnosis has been set by a clinician. Medical journals 
from the hospitalization of the event was required in order to evaluate the diagnosis and thus 
patients where these were unavailable were not accessible for validation. The evaluation was 
performed using a standard questionnaire for validation of acute myocardial infarction used in 
Coloma et al [55], modified to include questions regarding ACHD (appendix 2). The 
modification includes questions regarding the nature of the heart defect, whether it was 
known prior to the infarction, possible symtoms or complications and heart surgeries. The 
diagnosis was then categorized as either correct, probable, improbable or incorrect. The 
primary validation was done by the medical student and validated by one of the other 
investigators. If disagreement, a third person was involved and a consensus decision was 
reached. Analysis of patients was performed according to sex and whether the CHD was 
known prior to the MI. Patients were also analyzed according to the severity of the CHD 
diagnosis. This was performed by using the hierarchical classification system was described 
by Liu et al [56] wich also has been used in other published studys [57-59]. Groups were 
categorized as following:  
• Lesion group 1, “conotruncal defects”: common truncus, 
aortopulmonary septum defect, transposition of great vessels, and tetralogy of Fallot.  
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• Lesion group 2, “severe nonconotruncal defects”: endocardial cushion defects, 
common ventricle, and hypoplastic left heart syndrome. 
• Lesion group 3, “CoA”: coarctation of the aorta 
• lesion group 4, “VSD”: ventricular septal defect and other defects of the cardiac 
septum. 
• Lesion group 5, “ASD”: atrial septal defect 
• Lesion group 6: all heart and circulatory system anomalies and all CHD diagnoses not 
included in the five groups above. 
In order to get a representation of the burden of risk factors between these groups, the 
presence of risk factors in total in the seperate group was identified. This number was then 
divided by the total number of patients in the group, wich produced a number corresponding 
to the mean burden of risk factors in this group.  
Statistics 
Since our study contained a small number of patients it was percieved that more sophisticated 
statistical methods would not have produced more relevant data. Because of this, only 
descriptive terms were used.  
Ethics 
Ethics is an important foundation in all scientific research. Our study, confined to the GUCH-
clinic of Västra Götalandsregionen, is a matter of quality control. As such, the ethical 
approval of the study was performed by the operations manager of the clinic, Maria Taranger. 
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Results 
 Age at MI-event ranged from 0 
to 90 with a median age of 54.2 
years. 53% (n = 17) of the 
patients were male and 47% (n 
=15) were female. Results from 
assessment of the probability of 
correct MI-diagnosis include 
9,4% (n = 3) incorrect, 9.4% (n 
= 3) improbable, 15.6% (n = 5) 
probable and 65.6% (n = 21) correct. Divided into two groups, with incorrect and improbable 
in one and probable and correct in the other, results are 18.8% (n = 6) incorrect or improbable 
and 87.6 (n = 28) probable or correct. Among males there were 11.8% (n = 2) incorrect, 
11.8% (n = 2) improbable, 17.6% (n = 3) probable and 58.8% (n = 10) correct and among 
females there were 6.7% (n = 1) incorrect, 6.7% (n = 1) improbable, 13.3% (n = 2) probable 
and 73.3% (n = 11) correct (figure 3). No significant difference could be detected regarding 
the validity of MI diagnosis between men and women. Number of patients in each group 
when dividing according to 
severity of the CHD were as 
follows: group 1 had 4. Group 2 
had 6. Group 3 had 1. Group 4 
had 2. Group 5 had 13 and 
group 6 had 5. Mean age at MI-
diagnosis according to severity 
of the CHD ranged from 36.5 in 
Figure 3 – Distribution of probability of the MI-diagnosis for males, females 
and total. Expressed in percent 
Figure 4 - mean age at MI according to the severity of underlying CHD. 1: 
conotruncal defects (n = 4). 2: severe nonconotruncal defects (n = 6). 3: CoA (n 
= 1). 4: VSD (n = 2). 5: ASD (n = 13) 6: Other (n = 5). 
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group 1 to 69 in group 3 
(figure 4). There were no 
significant difference 
regarding probability of 
diagnosis when categorizing 
cases according to the severity 
of the CHD. Risk factors: The 
most prominent risk factors 
where hypertension with 65.6% (n = 21) and dyslipidemia at 46.9% (n = 15) and 12.5% (n = 
4) of patients did not have any risk factors on record (figure 5). The distribution of risk factors 
according to the severity of the CHD is presented in figure 7. Mean burden of risk factors for 
all patients was 1.81. Calculation of mean burden of risk factors for each severity group 
resulted in the following results: Group 1 - 1.75. Group 2 – 1.66. Group 3 – 1.00. Group 4 – 
2.50. Group 5 – 1.92 and group 6 – 2.00. The most common CHD diagnosis was ASD (37.5% 
n=12 patients), followed by VSD and Ebsteins anomaly with 6.25% (n = 2) patients each. The 
age at diagnosis 
of a CHD varied 
from infant to 81 
years old, with a 
mean age of 47.5 
years. With the 
patients 
diagnosed as 
Figure 5 - Risk factors for CAD, total. Expressed in percent. 
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Figure 6 - Probability of correct diagnosis of myocardial infarction, according to wether the CHD 
was known prior to the myocardial infarction or discovered as a result of it. Expressed in percent 
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infants excluded mean age was 57 years. In 46.9% (n=15) of cases the ACDH was discovered 
as a result of diagnostics following the MI, the most prominent was ASD at 66.7% (n=10) of 
the previously unknown diagnoses. When focusing on ASD alone, 76.9% (n=10) of cases was 
diagnosed after the MI and when excluding ASD, mean age for getting i CHD diagnosis was 
22.4 years. A comparison regarding the probability a correct MI-diagnosis between those who 
already had a CHD-diagnosis at the event and those who´s CHD was diagnosed as a result of 
the MI (figure 6). A comparison regarding risk factors for CAD revealed that the distribution 
was quite even. The exception was for cigarette smoking (53.3% among undiagnosed and 
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Figure 7 - Risk factors distributed according to severity of the CHD. Expressed in percent. 1: conotruncal defects (n = 4). 2: 
severe nonconotruncal defects (n = 6). 3: CoA (n = 1). 4: VSD (n = 2). 5: ASD (n = 13) 6: Other (n = 5) 
Figure 8 - Risk factors present according to whether the CHD diagnosis was known prior to the MI or not. Expressed in 
percent.  
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11.8% among diagnosed) and no risk factors present (0% among undiagnosed and 23.5% 
among diagnosed) (figure 8). The most prominent previous sign or symtom of CHD which 
might affect the MI-diagnostics was abnormal EKG patterns, present in 7 patients and one 
patient with a pacemaker. There was one patient who was reported to experience chest pains 
before the MI. There were no patients who was reported to present elevated levels of 
troponins before the MI. There were 8 patients who had underwent open heart surgery for 
their CHD, and 10 who had underwent catheterization. 
Discussion 
MI-diagnosis 
Our results show that an incorrect diagnosis was present in 9.4% (n = 3) of all cases and 9.4% 
(n = 3) were categorized as improbable. A probable diagnosis was present in 15.6% (n = 5) of 
cases and correct diagnosis represented 65.6% (n = 21) of cases. While this manor of 
presenting data, as four categories instead of a binary choice of correct or incorrect, does give 
a more nuanced image it also creates some difficulties when comparing our findings to the 
findings of other studys. For this purpose, it is worth seperating these into two categories, 
correct + probable (CP) and improbable + incorrect (II). When presented in this manor, the 
results are 81.3% (n = 26) in the CP-group, and 18.8% (n = 6) in the II-group.  
This is the first study to attempt to validate the MI diagnosis in adults with a CHD. This 
makes us unable to compare our findings with similar studys. At 81.3%, our result is lower 
than found by several studies conducted on a general population, including Lindblad et al who 
could confirm 96% of MI diagnoses [60] as well as Emily S. et al who found a specificity of 
0.979 to 0.993, depending on wich method that was used [61]. Another study by Coloma et al, 
conducted in Denmark, compared the PPV of codes from the International Classification of 
Primary Care (ICPC), International Classification of Diseases 9th revision-clinical 
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modification (ICD9-CM) and ICD-10th revision (ICD10) and found that the ICD-10 codes 
had a PPV of 100%, and ICD9-CM and ICPC had 96.6% and 75% respectively [55]. Since 
ICD-10 is the system used in Sweden, and Denmark has as a society and medical system in 
specific close to swedish conditions, the results from the Danish study might be the ones most 
valid for our study. So in general, studies have found PPV´s that vary from 95 - 100%. In light 
of these numbers, our results suggests that adult patients with a CHD indeed does recieve an 
incorrect or improbable MI diagnosis at higher rates compared to the general population, or at 
least that their MI diagnosis are more disputable. It is important, though, to take into account 
that our study has a small sample size compared to other studies, a reality facing most studies 
concerning patients with a CHD. In the Euro Heart Survey on adults with congenital heart 
disease conducted by Engelfreit et al (11) wich included 4 168 patients they found only 1% 
(n=34) who had had either an MI, Coronary Artery Bypass Graft (CABG) or a Percutaneous 
transluminal coronary angioplasty (PTCA) at baseline. 
In this study, we could not find a significant difference between male and female patients 
regarding the validity of the MI diagnosis. 
Regarding risk factors, our findings are at consistently higher rates compared to studies 
conducted on general CHD-patients. Hypertension, for instance, were present in 65.6%. Other 
studies have found rates at eg. 4% or 13% in a general CHD-population (11, 34), and in a 
study conducted on an older population (>65 years) they found that 47% were hypertensive 
(14). This is also true regarding the prevalence of diabetes, wich in our study was found to be 
18.8%. A study conducted in the Netherlands by Zomer et al (62) did report a significantly 
higher prevalence of diabetes in a CHD-population (3.4%) compared to the control group 
(2.3%). The finding of this study, being conducted on patients with an MI-diagnosis, confirms 
the notion that it is the commonly known risk factors for CAD that predicts the incidence of 
MI, found in several studies (14, 16, 34, 36)  
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We found no cases in the setting of the emergency ward where a patient presented symtoms 
of an acute MI and recieved an incorrect or improbable diagnosis. To return to the question 
regarding what happens in the emergency ward when a patient with a CHD enters with 
symtoms of acute MI, the typical cases evaluated in this study can be divided into two major 
scenarios.  
1. The CHD has not been diagnosed previously and thus, the patient is treated just like 
any other and undergoes the standardized procedures, and is diagnosed using 
troponins, electrocardiogram. 
2. The patient has a previously known CHD, in wich case they do go through the 
standard procedures using troponins, electrocardiograms and most often a percutaneus 
coronary intervention (PCI). The major difference seems to be that the presence of a 
CHD lowered the bar for taking these tests and proceeding in the MI diagnostics. And 
thus, there does not seem to be a significant risk that an MI is missed in patients with 
CHD. 
It is also worth noting that we found few cases with previous signs or symtoms of the CHD, 
and in cases were these were present, they do not seem to have played any significant role. 
Indeed, all of the cases were these were present were either classified as correct or probable. 
When scrutinizing an individual case classified as incorrect, this revealed that this was due to 
the patient not showing signs of an acute MI. Instead it had to do with findings of 
hypoperfusion in some areas during an scintigraphic heart examination wich at first hand was 
interperated as signs of an old infarction, but later was interperated as effects of an 
eisenmangers syndrome. There were also cases where it was believed that the myocarida had 
been damaged during a procedure, but where it was unclear whether it should be classified as 
an MI or not. The same trends can be seen among the cases that was classified as improbable. 
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Patients who´s CHD diagnosis was unknown prior to the MI 
15 of the 32 patients included in this study were cases where the CHD was discovered as a 
result of the MI. After being diagnosed with an MI, all patients in Sweden undergo an 
examination to determine the extent of the damage caused by the MI, typically using 
ultrasound. This ”MI-driven diagnostics” of CHD phenomena was not something that we 
expected to find when initiating this study and it somewhat disrupts our initial question, since 
a part of it had to do with how the presence of an CHD effects the doctor at the emergency 
ward. If the CHD is unknown then the patient is probably managed just like any other patient 
presenting these symtoms. When comparing the validity of the MI-diagnose in those with a 
previosly diagnosed CHD to the ones who recieved the CHD diagnose as a result of the MI, 
no significant differences could be found (figure 6). A broader comparison between the two 
groups showed that there were some differences. For one thing, one might suspect that 
patients with a previously undiagnosed CHD would have less severe lesions, and it is true that 
10 out of the 15 patients did have ASD. In light of that, one might expect that there would be 
lower rates of hypertension in this group, when in reality it was actually higher (73.3% 
compared to 58.5%). This might be due to the fact that the patients with less severe CHD 
diagnoses, such as ASD, had a higher mean age at the time of the infarction. (Another aspect 
of the same phenomena could account for the fact that all patients who was reported to have 
no risk factors were cases where the CHD-diagnose was known before the infarction, namely 
that they would have more severe CHD diagnoses and therefore be younger at MI diagnosis). 
The observation that the risk factors are distributed quite evenly dispite the fact that patients 
in group 5 are older than patients in group 1 indicates that the patients with more severe 
lesions develop risk factors for CAD earlier than those with less severe diagnoses. In the case 
of diabetes, the rates are even slightly higher than in group 5 (23.5% compared to 13.3%). 
Lastly, the patients who were undiagnosed before the MI had cigarette smoking as a risk 
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factor at much higher rates compared to the other group (53.3% compared to 11.8%). This is 
in line with a study by, Moons P et al, who not only found that 80% of adults with a CHD 
diagnosis had at least 1 or more cardiovascular risk factor, but they also had fewer smokers, 
and even though they participated in sports activities at a higher rate then the general 
population, they had a higher prevalence of hypertension and diabetes [34]. 
 
Comparing according to severity of underlying CHD 
When dividing cases into 6 different categories according to the severity of the underlying 
CHD diagnose several implications can be found, but there are two aspects that needs to be 
accounted for when attempting to draw any conclusions from this analizes. First of all that 
group 6 is quite different from the other 5 groups. While these are ordered as a falling scale of 
severity of the CHD, group 6 is categorized as any CHD which does not fall under any of the 
other categories. As a result, this group should not be viewed as the mildest on a continous 
scale of severity of the CHD. In fact, this group includes patients with abnormal coronary 
arteries, wich in one case led to a fatal MI in the patients 20´s. Secondly, this study has quite a 
small sample to start with and dividing these into even smaller groups creates challenges. 
Group 3 (coarctation), for instance, merely consist of 1 patient, and group 4 (VSD) consists of 
2 patients. With groups so small it is impossible to draw any conclusions, so this needs to be 
taken into account when analyzing the data. The low number of patients with a VSD in our 
study might seem surprising, considering how common these patients are compared to other 
CHD. Studies conducted on a general CHD-population report a higher prevalence of VSD, 
such as Engelfreit et al (11) at 15.3%. But this is in line with findings by Fedchenko et al. 
(12), in part conducted on the same cohort, where these patients constituted 19.9% of the 
study population but had the lowest incidence of ischemic heart disease (IHD) at 31.2 cases 
per 100 000 person-years compared to 71.1 cases per 100 000 person-years among patients 
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with conotruncal defects. The same is true for coarctation of the aorta, at 44.6 cases of IHD 
per 100 000 person-years. As the presence of an MI is required for inclusion into our study, 
this leads to a low prevalence of VSD and coarctation of the aorta, confirming the findings of 
said article.  
For one thing, mean age at MI diagnosis seems to decrease with more severe CHD diagnoses. 
Group 1, the most severe CHD diagnoses, have the lowest mean age at 36.5 years while group 
5 has the highest, at 66.9. The exception to this trend is group 3 at 69 years, but since this 
group 3 actually is only one individual it is difficult to know how to evaluate its significance. 
This is in line with findings of Mandakenakis et al (5) and Engelfreit et al (11). These findings 
are also in line with findings in Fedchenko et al (12), which uses the same classification 
system for CHD according to severity. In the study, the highest rates of ischemic heart disease 
could be found among patient in the two most severe lesion groups (conotruncal defects and 
nonconotruncal defects), and they could identify a rapidly increased incidence of IHD from 
around 20 years of age in the CHD-group, not found in the control group. The distribution of 
risk factors were quite even across the different groups with two exceptions. First is the fact 
that group 5 (ASD) scores high in dyslipidemia, diabetes, hypertension and especially 
cigarette smoking. This finding is in line with Moons P et al, mentioned above [34]. The 
exception is, once again, group 3 and 4, but it is difficult to know what conclusions could be 
drawn from this because of the reasons stated above regarding these groups. 
Limitations 
One obvious limitation to this study is the small sample size. Part of this has to do with the 
quite narrow focus of the study. Although heart defects are the most common major 
congenital defect, there are often not enough patients to conduct large scale quantitave 
studies. Even more so when focusing on those with myocardial infaction as well. It also has to 
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do with problems we have faced when trying to retrieve data for the study. Originally, the 
study was designed to be a national study, including all patients with any ACHD-diagnosis as 
well as heart infarction in all of Sweden. The application for ethical approval for such a study 
has been approved. When applying to retrieve this data from the Swedish Health Registery, 
though, there was a 6 month waiting period for getting this data, making it accessable to us in 
the beginning of fall 2017. Since the study was to be conducted during the first half of 2017, 
there was simply no time to wait for this data. Therefore, we decided to use local data instead, 
which inevitably led to a smaller sample size. 
Furthermore, the study was originally designed to include patients as early as 1975, but as the 
work to extract local data was initiated it became clear that we did not have access to records 
predating 2000. This further reduced our sample size. 
Another limitation is the focus solely on myocardial infarction. One could argue that 
myocardial infarction as the last stage on a continuous scale of Coronary Artery Disease. In 
that perspective, a study on the diagnostics of myocardial infaction without adressing its 
precursors is insufficiant. Our study initially aimed to take these aspects into account as well, 
but was once again forced to narrow the focus to myocardial infarction due to lack of time, 
since the final data became available in mid april. When faced with this problem, instead of 
including the diagnostics of CAD-diagnoses in the study, we decided to use the patients in our 
dataset with these diagnoses as a kind of concentrated group of ”high risk” patients for 
myocardial infarction, and thus performe a free-text search for ”infarction” in order to make 
sure that no stones were left unturned. This revealed that, among the 62 patients not on record 
as having myocardial infarction in our dataset, 28 of these actually had the diagnosis. Why 
our dataset was unable to detect these patients is unclear, but it begs the question if there are 
more patients who do meet the inclusion criteria but that our dataset was unable to detect and 
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therefore not included in this study. In order to perform quality research in the future, this 
problem needs to be adressed. 
And lastly there are limitations related to the study design. For one thing, the design of this 
study does not allow evaluation of cases where a patient has recieved a false negative 
diagnosis, that is when there truly is an MI but they are not diagnosed as such. Furthermore, 
the way this study was designed, as a retrospective study based on reviewing medical records, 
makes it entirely dependent on the clinician at the time and how thorough he or she has been 
intervjuing the patient and in the journal. This in turn makes it difficult to evaluate the extent 
and accuracy of some of the data retrieved. The presence of risk factors, for example, is one 
area particularly affected by this. It is only when there has been a mention of heredity or 
obesity, for example, that this data has been able to be included. But to what extent the 
various risk factors has been asked about specifically is unknown and it is quite probable that 
the focus from the various clinicians is variable. One implication of this is the fact that there 
are only 1 patient registered as having a sedentary lifestile, while associated conditions such 
as obesity, diabetes mellitus, hypertension and dyslipidemia where much more common in 
this dataset. And it is important to note that the ones registered as having none of the risk 
factors could indeed have risk factors, only that they were never mentioned in their medical 
records. This uncertainty is also important to keep in mind in the case of previous signs and 
symtoms. Still, a part of the aim of this study is how the diagnostics of these patients are 
affected by symtoms of their ACHD-diagnosis and one might argue that the fact that these are 
mentioned so little in the medical journals might suggests that they do not play any significant 
role. 
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Conclusions 
In this study we found that adult patients with a CHD are more likely to recieve an incorrect 
or improbable diagnosis of MI than the general population, and only 65.6% of the diagnoses 
evaluated considered to fully conform to the diagnostic criteria. When dividing these into two 
groups, correct/probable and improbable/incorrect, the results are 81.3% and 18.8% 
respectively. But this differance does not seem to be valid in the setting of a patient presenting 
symtoms of an MI in the emergency ward. The reduced rates of correct diagnostics seems to 
mainly stem from difficulties of evaluating signs of an old MI, or how to classify myocardial 
damage during a surgical procedure. How do you evaluate, for instance, whether a 
hypoperfusioned area on a scintigraphic exam or an abnormal electrochardiogram originates 
from an silent MI or from the patients CHD? In these instances there can truly be an overlap 
between the manifestations of an MI and the CHD, making the diagnostics troublesome. In 
order to resolve these issues, more specific and informative methods of examening the heart 
may be required, such as MRI with gadolinium contrast in order to identify scarring of the 
heart muscle tissue and old MI´s. Considering the recent and ongoing development in the 
population with CHD, further research is needed. The trends visible in this study is based on a 
small cohort, and further studies on larger cohorts is needed. 
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Populärvetenskaplig sammanfattning 
Medfödda hjärtfel är den vanligaste formen av allvarliga medfödda strukturella 
missbildningar. 1 barn av 100 drabbas, eller ca 1,35 miljoner barn per år världen över. 
Missbildningarnas svårighetsgrad varierar stort, från de som lever långa liv utan att ens 
upptäcka sitt hjärtfel till de som dör bara timmar efter födseln utan större kirurgiska och 
medicinska insatser. Det finns även allt där emellan. 
Framtidsutsikterna för dessa barn har i västvärlden förbättrats enormt de senaste årtiondena. 
Sedan 1950-talet har överlevnaden till vuxen ålder ökat från cirka 20% till dagens 95%. Men 
de har i genomsnitt lägre livskvalitet och ökad sjuklighet samt dödlighet jämfört med övriga 
befolkningen, nyare forskning har bland annat visat en ökad risk för hjärtinfarkt i unga åldrar. 
Hand i hand med ökad överlevnad följer även att dessa patienter, som grupp, blir fler och 
äldre. Dessutom - i takt med att vården klarar av att rädda personer med allt allvarligare 
hjärtfel gör detta att patientgruppen som helhet får en ökad allvarlighetsgrad i sin 
grundsjukdom, vilket är associerat med lägre livskvalitet och ökad sjuklighet samt dödlighet. 
Vi har mycket begränsad kunskap om hur dessa patienter svarar på ökande ålder. 
Denna utveckling utmanar sjukvården och ställer krav på bra forskning. Men forskning kan 
aldrig vara bättre än den data som ligger till grund, och när det gäller risken för hjärtinfarkt är 
det svårt att veta hur tillförlitlig vår data är. Detta eftersom flera av symptomen på hjärtinfarkt 
även kan orsakas av ett medfött hjärtfel och det kan därför vara svårt för en läkare att avgöra 
vad som orsakar en patients tillstånd. Vi vet därför inte om vi kan lita på de 
hjärtinfarktdiagnoser som läkare har satt, och därmed dras forskningen alltid med osäkerhet. 
Denna studie syftar till att utvärdera de hjärtinfarktdiagnoser som har satts på vuxna patienter 
med medfödda hjärtfel i Västra Götalandsregionen. 
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Vi fann 32 vuxna patienter med medfött hjärtfel under perioden 2000 - 2017 fått en 
hjärtinfarktdiagnos. Vi granskade deras journaler och utvärderade hjärtinfarktdiagnosen 
utifrån de internationella diagnoskriterierna för hjärtinfarkt. Vi fann 66.6% (21 st) korrekta, 
15.6% (5 st) sannolika, 9.4% (3 st) osannolika och 9.4% (3 st) inkorrekta.  
Även om detta är en liten studie så är 66,6% korrekta är ett resultat som är mycket lägre 
jämfört med patienter utan medfött hjärtfel. Nordiska studier på området visar en korrekt 
diagnos i 95 - 100% av fallen. Samtliga diagnoser som klassats som inkorrekta rörde sig om 
fall där man hittat tecken på en redan genomgången hjärtinfarkt, men där det fanns svårigheter 
att avgöra huruvida det bör klassas som hjärtinfarkt eller som orsakat av hjärtmissbildningen. 
Fynden ställer vissa frågetecken kring tillförlitligheten i forskningen på området, men de 
pekar också åt att då dessa patienter söker akuten för en pågående hjärtinfarkt kan de lita på 
att de diagnostiska metoder som används fungerar. 
För att få bukt med detta bör man finna nya sätt att utvärdera tecken till en redan 
genomgången infarkt, t.ex. med hjälp av nya bildtekniker såsom magnetkamera med 
kontrastmedel. För att utvärdera dessa resultat krävs även mer forskning. 
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Appendix 1, the ICD-10 codes used for identifying cases 
• CHD 
o Q203 – Diskordant ventrikulo-arteriell förbindelse D-TGA 
o Q205 – Diskordant ventrikulo-arteriell förbindelse L -TGA 
o Q210 – Kammarseptumdefekt 
o Q211 – Förmaksseptumdefekt 
o Q213 – Fallots tetrad 
o Q220 – Atresi av pulmonalisklaff 
o Q224 – Medfödd tricuspidalisstenos 
o Q225 – Ebsteins anomali 
o Q230 – Medfödd aortaklaffstenos 
o Q231 – Medfödd aortaklaffsinsufficiens 
o Q232 – Medfödd mitralisstenos 
o Q233 – Medfödd mitralisinsufficiens 
o Q234 – Hypoplastiskt vänsterkammarsyndrom 
o Q241 – Levokardi 
o Q245 – Kranskärlsmissbildning 
o Q249 – Medfödd hjärtmissbildning, ospec 
o Q250 – Öppetstående ductus arteriosus 
o Q251 – Coarctatio aortae 
o Q253 – Stenos av aorta 
o Q254 – Andra medfödda missbildningar av aorta 
o Q257 – Andra medfödda missbildningar av lungartären 
o Q261 – Kvarstående vänstersidig övre hålven 
o Q263 – Partiellt anomailt mynnande lungvener 
o Q269 – Medödd missbildning av de stora venerna, ospec. 
• CAD 
o I200 – Instabil angina pectoris 
o I208 – Andra former av angina pectoris 
o I209 – Angina pectoris, ospec 
o I210 – Akut transmural framväggsinfarkt 
o I212 – Akut transmural hjärtinfarkt med andra lokalisationer 
o I213 – Akut transmural hjärtinfarkt med icke specificerad lokalisation 
o I214 – Akut subendokardiell infarkt i framvägg 
o I219 – Akut hjärtinfarkt, ospec 
o I230 – Hemoperikardium som komplikation till akut hjärtinfarkt 
o I231 – Förmaksseptumdefekt som komplikation till akut hjärtifarkt 
o I248 – Andra specificerade former av akut ischemisk hjärtsjukdom 
o I250 – Aterosklerotisk kardiovaskulär sjukdom 
o I252 – Gammal hjärtinfarkt 
o I251 – Andra hjärtsjukdomar vid andra infektionssjukdomar och 
parasitsjukdomar som klassificeras annorstädes 
o I259 – kronisk ischemisk hjärtsjukdom, ospec 
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Appendix 2, questionnaire used to evaluate the MI diagnosis: 
Questionnaire for assessors 
◦ Database: __________________________ 
◦ ID Patient: _________ 
◦ Sex: M/W 
◦ Birthdate: ___/__/__ 
◦ Diagnosis: _____________ 
◦ Date of event/diagnosis: ____/__/__ 
◦ Age at event/diagnosis: ___ years 
◦ Is there a medical record available for this patient? 
▪ Yes/No 
◦ Is there sufficient information in order to validate the diagnosis? 
▪ Yes/No 
◦ Diagnosed by senior doctor in cardiology or GUCH 
▪ Yes/No 
◦ A) Information on characteristics and detection of AMI 
▪ 1. Was there any mention of the presence of ‘acute myocardial infarction’ in the records 
reviewed? 
• Yes/No 
▪ 2. If (Answer to 1 is) YES, was the myocardial infarction referred to as ‘old myocardial 
infarction’ or ‘history of myocardial infarction’? 
• Yes/No 
▪ 3. Was there an explicit mention of ‘acute myocardial infarction’ as a cause of death? 
• Yes/No 
▪ For Questions 4-6, evaluate within 30 days of presumed index date [i.e., date of diagnosis] 
▪ 4. Were any of the following interventions done? Multiple answers are possible: 
• Coronary artery bypass graft (CABG) 
• Percutaneous coronary intervention (PCI) 
• Thrombolysis (rTPA/streptokinase, others) 
• Initiation of long-term pharmacotherapy 
• None of the above 
▪ 5. Were any of the following examinations done to confirm a suspicion of acute myocardial 
infarction? Multiple answers are possible: 
• Coronary angiography (specify findings if possible) 
◦ coronary occlusion 
◦ coronary obstruction 
◦ vessel narrowing 
◦ ruptured plaque 
◦ other, please specify _____________________ 
• Electrocardiography (ECG) (specify findings if possible) 
◦ ST-segment elevation>1mm in 2 anatomically contiguous leads 
◦ new Q waves 
◦ new left bundle branch block (LBBB) 
◦ T wave inversion 
◦ Other, please specify _________________ 
• Cardiac enzymes (specify values and units, if given) 
◦ Elevated levels of Troponin T_______________ 
◦ Other, specify if possible__________________ 
◦ None of the above 
▪ 6. Were any of these signs or symptoms of myocardial ischemia recorded shortly on or before 
the date of diagnosis? Multiple answers are possible: 
• chest, jaw or upper extremity pain at rest or with exertion 
• difficulty breathing (dyspnea) 
• excessive sweating (diaphoresis) 
• fatigue/weakness 
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• epigastric pain 
• none of the above 
• other, please specify _______________________ 
◦ B) Information about cardiovascular risk factors 
▪ 1. Was there mention/evidence in the records of any of the following risk factors for acute 
myocardial infarction? Multiple answers are possible. 
• Family history of myocardial infarction/cardiovascular disease 
• Dyslipidemia 
• Diabetes mellitus 
• Hypertension 
• Obesity 
• Cigarette smoking 
• Sedentary lifestyle 
• None of the above 
▪ Were these risk factors detected as a result of the myocardial infarction? 
• Yes/No 
• If yes, please specify______________________ 
◦ C) Information about congenital heart defect, previous signs/symptoms/complication. 
▪ CHD diagnosis _______________________________________ 
▪ Age at diagnosis _________ 
▪ Was the CHD-diagnosis known prior to the myocardial infarction? 
• Yes/No 
• If no, was is detected as a result of the myocardial infarction? 
◦ Yes/No 
▪ Previous signs/symtoms/complications 
• Abnormal ECG-patterns 
◦ Please specify________________________________________________ 
◦ ____________________________________________________________ 
• Elevated levels of troponin 
◦ From___ to ___ Median_____ 
• Chest pains 
• Number of cardiac surgeries 
◦ Open_________ 
◦ Catherization__________ 
◦ Involving manipulation of coronary arteries 
▪ Yes/No 
• Other______________________________________ 
◦ D) Information about potential alternative explanations for the signs/symptoms/ laboratory 
findings 
▪ 1. Was there mention/evidence in the records of any of the following diseases at the time 
of/before the diagnosis? Multiple answers are possible. 
• Pericarditis and/or Cardiac Tamponade ________________ 
• Myocarditis ___________________________________ 
• Aortic dissection _______________________________ 
• Cardiac contusion ______________________________ 
• Pneumothorax _________________________________ 
• Pulmonary embolism ______________________________ 
• Stable angina ____________________________________ 
• Unstable angina __________________________________ 
• Gastroesophageal reflux disease (GERD) ______________ 
• None of the above 
◦ E) Estimated probability of diagnosis 
▪ Correct 
▪ Probable 
▪ Inprobable 
▪ Incorrect 
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Other comments 
__________________________________________________________________________ 
__________________________________________________________________________ 
 
 
 
